AXOGEN INC. - COMMON STOCK

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

02 Feb 2024 15:15:00 By Nasdaq GlobeNewswire

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

18 Jan 2024 16:00:00 By Nasdaq GlobeNewswire

Axogen Reports Preliminary Unaudited Revenue for Fourth Quarter and Full-Year 2023

04 Jan 2024 15:45:00 By Nasdaq GlobeNewswire

Axogen Announces Plan for Leadership Transition with CEO Karen Zaderej to Retire from Company by January 2025

04 Jan 2024 15:40:00 By Nasdaq GlobeNewswire

Axogen Announces Promotions on Research and Development Team

04 Jan 2024 15:35:00 By Nasdaq GlobeNewswire

Axogen, Inc. Appoints Kathy Weiler to its Board of Directors

26 Dec 2023 15:15:00 By Nasdaq GlobeNewswire

Axogen Announces Transition of Finance Team Leadership

06 Dec 2023 06:00:00 By Nasdaq GlobeNewswire

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

01 Dec 2023 16:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference

20 Nov 2023 06:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 Third Quarter Financial Results

07 Nov 2023 06:00:01 By Nasdaq GlobeNewswire

Axogen, Inc. to Report Third Quarter 2023 Financial Results and Host Conference Call on November 7, 2023

18 Oct 2023 06:00:00 By Nasdaq GlobeNewswire

Axogen to Participate at Upcoming Investor Conferences

31 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Begins Processing Avance® Nerve Graft at New State-of-the-Art Facility in Dayton, Ohio

21 Aug 2023 06:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 Second Quarter Financial Results

07 Aug 2023 15:01:10 By Nasdaq GlobeNewswire

Axogen to Participate at Canaccord Genuity’s 43rd Annual Growth Conference

27 Jul 2023 06:00:01 By Nasdaq GlobeNewswire

Axogen, Inc. to report second quarter 2023 financial results and host conference call on August 7, 2023

26 Jul 2023 06:00:01 By Nasdaq GlobeNewswire

Axogen to Participate at Jefferies Healthcare Conference

24 May 2023 06:00:00 By Nasdaq GlobeNewswire

Axogen to Participate at JMP Securities Life Sciences Conference

12 May 2023 06:00:00 By Nasdaq GlobeNewswire

Axogen, Inc. Reports 2023 First Quarter Financial Results

09 May 2023 06:00:03 By Nasdaq GlobeNewswire

Axogen, Inc. to report first quarter 2023 financial results and host conference call on May 9, 2023

18 Apr 2023 15:05:00 By Nasdaq GlobeNewswire